Coherus
Coherus is a leading biologics platform company, solely focused on developing and commercializing high-quality biosimilars. CHS-1701 (pegfilgrastim biosimilar) is the furthest advanced of the late-stage clinical products. Biosimilars are intended for use in place of existing branded biologics to treat a range of often life-threatening conditions, with the potential to reduce costs and expand patient access.